4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Vyome Holdings, Inc. (HIND) operates in the Biotechnology industry and is headquartered in Cambridge, United States with about 9 employees. Its market capitalization is roughly $15 million. In the fiscal year ended 2025-12-31, HIND reported $0M in revenue and ($10M) in net income.
Vyome Holdings, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States. It operates through Pharmaceutical and Biotechnology segments.
Interactive charts & full statements → Open the HIND valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Gross Profit | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($3M) | ($1M) | ($1M) | ($1M) |
| Net Income | ($10M) | ($1M) | ($1M) | ($1M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Gross Profit | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($1M) | ($1M) | ($1M) | ($0M) | ($0M) |
| Net Income | ($1M) | ($1M) | ($9M) | ($0M) | ($0M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $6M | $1M | $1M | $2M |
| Total Liabilities | $3M | $6M | $8M | $7M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive HIND viewer.
About TickerBase · Data methodology & sources